Member Info for andinio

It seems, having reviewed this and other investor threads - that sentiment and bulls are at an all-time low for Bidstack.
It appears we've reached a point where regular bears can't even be bothered to post their 'regular' downbeat comments and bulls appear less vocal.
Arguably, the squeeze is closing in. Traders will be amongst us shortly to light the dry touchpaper.
Expecting some activity in the short term.
Perhaps James would like to elevate the share above such movements. We will see.

JackpotJoywinner
Yep, JW is both the hooker and the pimp.
Like all good hookers he'll find a market. But, he'll always be a hooker wit cash on the hip.

The platform for the podcasts is fine IMO. How JW uses his position is - at best - questionable.
What makes me smile about JW is that he's actually started believing his own bull.
Put it like this, how about he records and transmits his podcast while keeping his private investment ideas private.
How well do you think his investments would do then????
JW is the 'dirty trader' and worse 'a dirty leach'.
Yet, his following strength cannot be ignored by investors. Knowing what he is punting, and knowing he lacks any integrity - allows investors to sell into worthless spikes and buy into poorly thoughout selling dips.
JW is the locust who hops from one crop to another. He will continue to make. He will continue to believe he is a seasoned investor. Such is the delusion ;)

"Clearly JW is not a LTH and a trader but then fair enough"
it would be fair enough except JW pretends to be a lth (in all his holdings) while actually conducting his portfolio as a 'dirty' trader [dirty trader being his term for those who buy and sell].
He - like others - is free to do as he wishes. I would suggest that integrity is not one of his character traits yet he demands it from directors.
JW isn't a clever 'dirty' trader or clever lth investor, he merely preys on PIs with little or no knowledge. His wins are based on mass of those who follow.
DYOR, always.

Less than 3% at 31st January.
5 trading days since then.

Good news.
Price holding up well as Jupiter exits stage left.

Cathal uses the RNS system correctly.
RNS Reach - as used by Orph for announcing investor events - is the correct tool for such announcements. Nothing unusual.

Roughly 500k to be spent in next six weeks to finance furher headcount reduction at Venn.
Revenues up since headcount reduction.

Cathal says Venn staff numbers down from 179 to roughly 100 since Orph took over Venn.
More restructuring coming this month = further headcount reduction.

I'm not sure what could be said in a podcast that wasn't adequately explained in the combined RNS release.
Much can be gleaned from wasn't said in the resignation RNS in combination with what was said later.
More is rarely enough for keen investors and a podcast at the moment has the potential to add to the churn of theories and conjecture.

This article from Science Daily was written in 2017
https://www.sciencedaily.com/releases/2017/02/170223144729.htm

It ends with....
..."Therefore, there still may be cause for concern about this type of virus. "There are likely hundreds of coronaviruses out there in bats," Leibowitz said. "We've only really seen two of them manifest as severe diseases in humans, and they all may have some potential for transmission to other species -- including us."
"I have no real doubt that there will be another outbreak of a coronavirus," Leibowitz added. "We don't know where or when or which one, but we need to be ready."

In the end i managed 100k over three trades.
My terminal froze @ 5.46 - damn annoying.
I was considering a position @ 7+ on Monday/Tuesday so can't complain about 6.04 avg.

Someone was royally fleeced this morning.

Tried to buy @ 4 @ 4.5 @ 5 @ 5.5
They mopped up sells and nailed down online buys.

Dan refers to Dave as being the person negotiating the monies due.
Has he fallen on his sword?
Doesn't quite add up.

What's with all the NFX resignations?

Friel says that, in December, just weeks into negotiations between Open Orphan and hVIVO, the latter company was able to go back to three existing challenge study customers and now offer additional services including CMC, Phase I, Phase II, Data and Statistics. In the past, hVIVO was never able to offer these services to existing customers despite regularly being asked. The enlarged group will use part of the proceeds from its recent placing to build up yet more revenues by taking advantage of more of these types of opportunities:

“hVIVO has a really sticky business model because it is a world leader in virology challenge studies. However, it has continually turned down work in the earlier preclinical and phase I trials and also had to turn down phase II clinical trials work that they get offered to do once the challenge study is completed, because, prior to its merger with Open Orphan, hVIVO did not have the capability to provide these clinical study services. On the other hand, we have never had enough work in those areas despite being able to service them – particularly phase 2 trials which are £10-£12 million contracts,” he said. “The two companies fit like a glove, and we will be pursuing new contracts and developed contracts with existing hVIVO customers moving forward.”

I'll pay £10 to HartlepoolBob if he sings these lyrics outloud at the next Bidstack AGM
https://www.youtube.com/watch?v=fj7V-P2g5LM

"He's a runner
You came into my life and tuned my head around
And just as quickly you put me down
Now you don't won't to know what I'm going through
Cause just like I said, it means nothing to you"

They also released a song 'The Runner'.
James, come back.
Perhaps the girls were 70's Bidstack prophets.
Sooner, or later, Mr. Draper will have to make an appearance. He probably knows, the next piece of newsflow to eminate from Bidstack will carry great weight with investors. Let's hope for Bidstack - and PIs - that what comes next is positive and tangible.

James, when will we see you again? :)